Data Exclusivity for Biologic Drugs: The TPP’s Potential Poison Pill?
Tina Cheung On October 5, 2015, after many years of secretive negotiations, the US government with 11 other countries across the Asia Pacific and Latin America reached an agreement on the largest free-trade deal in history, the Trans-Pacific Partnership (TPP). Addressing everything from wildlife conservation and tax reductions for agriculture, to the free flow of information on the Internet and intellectual-property rights for movies and pharmaceutical drugs, this far-reaching agreement has the potential to impact up to one-third of world trade. One of the most contentious parts of the agreement involves intellectual property rights of pharma companies to data exclusivity...
The Trans-Pacific Partnership on Internet Service Providers: Notice, Counter-Notice, and Liability Limitations
Joseph Davi With the recent release of the Trans Pacific Partnership (TPP) intellectual property chapters, jurists and pundits have quickly begun to comb through the language and pick apart the intriguing and possibly soon-to-be influential document. While many have focused on this document’s proposed changes to the way copyright holders and infringers interact with their governments, each other, and each other’s governments, it is very important to stop and try to understand the changes that are more ground level. More specifically, it is worthwhile to take a close look at the proposed changes in how copyright holders and infringers interact...